Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Lippo Karawaci TbkISX:LPKR 68 Days Payable is 42.58 as of Mar. 2026, which is 7% below its 10-year median of 46.03. GuruFocus rates ISX:LPKR with a GF Score™ of 68/100 and a GF Value™ of Rp60.74 (Fairly Valued). The stock has 4 warning signs investors should review. Among 607 Healthcare Providers & Services companies, PT Lippo Karawaci Tbk ranks worse than 69.85% on this metric.
The historical rank and industry rank for PT Lippo Karawaci Tbk's Days Payable or its related term are showing as below:
ISX:LPKR'
s Days Payable Range Over the Past 10 Years
Min: 32.37 Med: 46.03 Max: 73.15
Current: 33.95
During the past 13 years, PT Lippo Karawaci Tbk's highest Days Payable was 73.15. The lowest was 32.37. And the median was 46.03.
ISX:LPKR's Days Payable is ranked worse than 69.85% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs ISX:LPKR: 33.95
PT Lippo Karawaci Tbk Days Payable Historical Data
* Premium members only.
The historical data trend for PT Lippo Karawaci Tbk's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:LPKR vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, PT Lippo Karawaci Tbk's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Lippo Karawaci Tbk Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Lippo Karawaci Tbk's Days Payable distribution charts can be found below:
* The bar in red indicates where PT Lippo Karawaci Tbk's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PT Lippo Karawaci Tbk's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Lippo Karawaci Tbk (ISX:LPKR) has a Days Payable of 42.58 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Lippo Karawaci Tbk and its competitors. This is near median its historical median of 46.03. Over the past decade, PT Lippo Karawaci Tbk's Days Payable has ranged from 32.37 to 73.15. According to the industry distribution chart, PT Lippo Karawaci Tbk ranks #424 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 69.9%.
Is PT Lippo Karawaci Tbk's Days Payable too high?
PT Lippo Karawaci Tbk's current Days Payable of 42.58 is near median its 10-year median of 46.03. Over the past 10 years, this metric has ranged from a low of 32.37 to a high of 73.15. The Healthcare Providers & Services industry median Days Payable is 57.13. PT Lippo Karawaci Tbk's value of 42.58 is 25.5% below this industry median. Based on the distribution chart, PT Lippo Karawaci Tbk ranks #424 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Lippo Karawaci Tbk has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Lippo Karawaci Tbk's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Lippo Karawaci Tbk ranks #424 out of 607 companies for Days Payable. This places PT Lippo Karawaci Tbk in the lower half of its industry. The industry median Days Payable is 57.13. PT Lippo Karawaci Tbk's value of 42.58 is 25.5% below this benchmark. Historically, PT Lippo Karawaci Tbk's own Days Payable has ranged from 32.37 to 73.15 over the past decade. While the company's 10-year median is 46.03 vs. the industry median of 57.13, PT Lippo Karawaci Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Lippo Karawaci Tbk's current Days Payable of 42.58 is 25.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Lippo Karawaci Tbk and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Lippo Karawaci Tbk's current Days Payable is 42.58, which is near median its own 10-year median of 46.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Lippo Karawaci Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Lippo Karawaci Tbk (ISX:LPKR) is currently considered Fairly Valued. The stock's GF Value™ is Rp60.74, compared to a current price of Rp60.00 — trading 1.2% below its estimated fair value. The current Days Payable is 42.58, which is near median its 10-year median of 46.03 and 25.5% below the Healthcare Providers & Services industry median of 57.13. PT Lippo Karawaci Tbk's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PT Lippo Karawaci Tbk (ISX:LPKR), the current Days Payable is 42.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Lippo Karawaci Tbk (ISX:LPKR) Overvalued in 2026?
Based on GuruFocus' analysis, PT Lippo Karawaci Tbk stock appears to be undervalued.
The current stock price of Rp60.00 is trading 1.2% below its estimated GF Value™ of Rp60.74.
GuruFocus considers PT Lippo Karawaci Tbk to be Fairly Valued.
Key valuation signals for ISX:LPKR:
Days Payable: 42.58 (near median its 10-year median of 46.03)
GF Value™: Rp60.74 vs. price of Rp60.00 (1.2% below fair value)
Industry Position: 25.5% below the Healthcare Providers & Services median (#424 of 607)
No single metric tells the full story. See the ISX:LPKR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Lippo Karawaci Tbk is engaged in property development activities including area development, residential property development and sales, commercial property, light industrial property, and integrated property projects. As part of its large scale integrated development portfolio, the Company develops projects within strategic locations comprising residential, office, mall, hotel, entertainment, education, and healthcare facilities. Its portfolio includes residential and urban development, hospitals, malls, and hotels and leisure assets. The Company has developed and manages urban property areas mainly in Java and Sulawesi, and operates across real estate, lifestyle, and healthcare segments, providing services across Indonesia.
68GF Score
Get the complete analysis for ISX:LPKR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:LPKR has been successfully added to your 
